TCI Wealth Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

TCI Wealth Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$9.09K	–	2394
2023 Q1	$9.09K	Hold	1,000	–	–	﹤0.01%	1148
2022 Q4	$11.7K	Hold	1,000	–	–	﹤0.01%	959
2022 Q3	$21K	Hold	1,000	–	–	﹤0.01%	646
2022 Q2	$24K	Hold	1,000	–	–	﹤0.01%	590
2022 Q1	$50K	Hold	1,000	–	–	0.01%	410
2021 Q4	$70K	Sell	1,000 -22	-2%	-$1.85K	0.01%	335
2021 Q3	$95K	Hold	1,022	–	–	0.01%	296
2021 Q2	$103K	Buy	1,022 +22	+2%	+$2.14K	0.02%	272
2021 Q1	$93K	Hold	1,000	–	–	0.04%	251
2020 Q4	$83K	Hold	1,000	–	–	0.04%	253
2020 Q3	$86K	Hold	1,000	–	–	0.03%	230
2020 Q2	$93K	Buy	1,000 +167	+20%	+$9.2K	0.04%	222
2020 Q1	$24K	Hold	833	–	–	0.01%	429
2019 Q4	$35K	Hold	833	–	–	0.01%	455
2019 Q3	$12K	Buy	833 +500	+150%	+$10.5K	0.01%	606
2019 Q2	$12K	Hold	333	–	–	0.01%	594
2019 Q1	$19K	Hold	333	–	–	0.01%	510
2018 Q4	$16K	Hold	333	–	–	0.01%	528
2018 Q3	$24K	Hold	333	–	–	0.01%	469
2018 Q2	$28K	Hold	333	–	–	0.01%	419
2018 Q1	$35K	Hold	333	–	–	0.02%	385
2017 Q4	$43K	Buy	+333	New	+$40.9K	0.02%	371
2016 Q3	–	Sell	-83	Closed	-$10K	–	1418
2016 Q2	$10K	Buy	+83	New	+$8.31K	0.01%	584

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCI Wealth Advisors's VBIV Position: Q2 2023 in Review

TCI Wealth Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 1,000 shares — an estimated $9.09K sold.

TCI Wealth Advisors first reported a position in VBIV in Q2 2016 and held it in 23 quarters. The position peaked at $103K in Q2 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

TCI Wealth Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 1,000 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $9.09K.
TCI Wealth Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2016 and held it in 23 quarters.
TCI Wealth Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $103K in Q2 2021.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.